Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Non-small Cell Lung Cancer Stage IIIB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00728845
What this trial is testing

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Medicine and Dentistry of New Jersey 8
Testing effectiveness (Phase 2)Looking for participantsNCT05281406
What this trial is testing

Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IV
Goethe University 50
Testing effectiveness (Phase 2)Study completedNCT00234052
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 51
Testing effectiveness (Phase 2)Study completedNCT02581943
What this trial is testing

Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05132985
What this trial is testing

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

Who this might be right for
NSCLCEGF-R Positive Non-Small Cell Lung Cancer
Liaoning Cancer Hospital & Institute 45
Large-scale testing (Phase 3)Looking for participantsNCT06623422
What this trial is testing

Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 680
Not applicableStudy completedNCT00419042
What this trial is testing

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Groupe Francais De Pneumo-Cancerologie 100
Testing effectiveness (Phase 2)Ended earlyNCT00346645
What this trial is testing

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

Who this might be right for
STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER
Gustave Roussy, Cancer Campus, Grand Paris 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06780839
What this trial is testing

Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD

Who this might be right for
NSCLC, Stage I, II, IIIA, IIIB
Peking University Cancer Hospital & Institute 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06109402
What this trial is testing

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Who this might be right for
Stage II-IIIB(N2) Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 160
Early research (Phase 1)Ended earlyNCT01574222
What this trial is testing

A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
VA Office of Research and Development 1
Post-approval studies (Phase 4)UnknownNCT04814056
What this trial is testing

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

Who this might be right for
NRG1-fused Non-small Cell Lung Cancer
Shanghai Chest Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT05286957
What this trial is testing

MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC

Who this might be right for
NSCLC
The First Affiliated Hospital of Zhengzhou University 60
Early research (Phase 1)Study completedNCT00496275
What this trial is testing

Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 17
Testing effectiveness (Phase 2)Study completedNCT00215930
What this trial is testing

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
H. Lee Moffitt Cancer Center and Research Institute 53
Testing effectiveness (Phase 2)Study completedNCT00874107
What this trial is testing

Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
HiberCell, Inc. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07156604
What this trial is testing

Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLCNeoadjuvant Therapy
Fudan University 30
Not applicableUnknownNCT02035683
What this trial is testing

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIIB
National Cancer Institute, Naples 220
Testing effectiveness (Phase 2)Study completedNCT00281970
What this trial is testing

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Ended earlyNCT04396535
What this trial is testing

Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+5 more
Mayo Clinic 10
Next Page